Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannes F Alber

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Wiener Klinische Wochenschrift|July 22, 2018
Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a reviewHannes F Alber, Kurt Huber
Wiener Medizinische Wochenschrift (1946)|January 17, 2017
[Secondary prevention with antiplatelet therapy in cardiac rehabilitation]Maria M Wanitschek, Hannes F Alber
Circulation|July 21, 2004
Endothelial function in a large communityMatthias Frick, Hannes F Alber, Franz Weidinger
Wiener Klinische Wochenschrift|August 11, 2005
[The role of inflammation in the pathophysiology of acute coronary syndromes]Hannes F Alber, Alois Suessenbacher, Franz Weidinger
The New England Journal of Medicine|July 29, 2016
Chronic Stable AnginaMaria M Wanitschek, Jakob Dörler, Hannes F Alber
Wiener Klinische Wochenschrift|July 30, 2011
Prasugrel vs. ticagrelor in acute coronary syndromes: which one to choose?Hannes F Alber, Kurt Huber, Otmar Pachinger, et al.
BMJ Open|June 9, 2018
Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohortMaria Wanitschek, Michael Edlinger, Jakob Dörler, et al.
European Heart Journal|May 8, 2007
Endothelial dysfunction and peripheral arterial diseaseMatthias Frick, Alois Suessenbacher, Hannes F Alber, et al.
Wiener Medizinische Wochenschrift (1946)|March 16, 2010
[STEMI guidelines 2008--Do they influence today's myocardial infarction treatment strategies in rural areas?]Alois Suessenbacher, Maria M Wanitschek, Jakob Doerler, et al.
Wiener Klinische Wochenschrift|August 11, 2005
Apical ballooning syndromeWolfgang Dichtl, Hannes F Alber, Guy Friedrich, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Wiener Klinische Wochenschrift|July 22, 2018
Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease-a reviewHannes F Alber, Kurt Huber
Wiener Medizinische Wochenschrift (1946)|January 17, 2017
[Secondary prevention with antiplatelet therapy in cardiac rehabilitation]Maria M Wanitschek, Hannes F Alber
Circulation|July 21, 2004
Endothelial function in a large communityMatthias Frick, Hannes F Alber, Franz Weidinger
Wiener Klinische Wochenschrift|August 11, 2005
[The role of inflammation in the pathophysiology of acute coronary syndromes]Hannes F Alber, Alois Suessenbacher, Franz Weidinger
The New England Journal of Medicine|July 29, 2016
Chronic Stable AnginaMaria M Wanitschek, Jakob Dörler, Hannes F Alber
Wiener Klinische Wochenschrift|July 30, 2011
Prasugrel vs. ticagrelor in acute coronary syndromes: which one to choose?Hannes F Alber, Kurt Huber, Otmar Pachinger, et al.
BMJ Open|June 9, 2018
Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohortMaria Wanitschek, Michael Edlinger, Jakob Dörler, et al.
European Heart Journal|May 8, 2007
Endothelial dysfunction and peripheral arterial diseaseMatthias Frick, Alois Suessenbacher, Hannes F Alber, et al.
Wiener Medizinische Wochenschrift (1946)|March 16, 2010
[STEMI guidelines 2008--Do they influence today's myocardial infarction treatment strategies in rural areas?]Alois Suessenbacher, Maria M Wanitschek, Jakob Doerler, et al.
Wiener Klinische Wochenschrift|August 11, 2005
Apical ballooning syndromeWolfgang Dichtl, Hannes F Alber, Guy Friedrich, et al.
Pageof 4